Tamsulosin Alkem 0,4 mg Capsule
PDF Leaflet Revision Date: 23 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of functional symptoms of benign prostatic hyperplasia (BPH).
Dosage (summary)
One capsule daily after breakfast.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not indicated for use in women; ejaculation disorders may occur.
Key Drug Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole)
- Moderate CYP3A4 inhibitors (e.g., erythromycin)
- Warfarin
Contraindications
- Hypersensitivity to tamsulosin
- Orthostatic hypotension
- Severe hepatic insufficiency
Common side effects
- Dizziness
- Drowsiness
- Ejaculation disorders
Counselling Points
- Take after the same meal daily
- Monitor for dizziness
- Report priapism immediately
Serious warnings
- Orthostatic hypotension
- Intraoperative Floppy Iris Syndrome (IFIS)
Important Disclaimer
The Tamsulosin Alkem 0,4 mg Capsule professional information leaflet below is the property of Alkem Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
